about
Statins for the primary prevention of cardiovascular diseaseStatins for the primary prevention of cardiovascular diseaseStatins and its hepatic effects: Newer data, implications, and changing recommendationsPeripheral neuropathy associated with simvastatin.Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarinStatin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of omanRisk factors associated with stool retention assessed by abdominal radiography for constipation.Pharmacology and clinical experience with simvastatin.Hepatitis, rhabdomyolysis and multi-organ failure resulting from statin use3 year simvastatin treatment and lens nuclear back scattering.Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.The case for more intensive use of statins.Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Potential role for statins in sickle cell disease.Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.Simvastatin-induced mononeuropathy multiplex: case report.Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses.
P2860
Q24201513-783D5776-909D-4667-B013-203649B9E778Q24234813-F6F1FADE-B326-4D2D-9FA2-B79AE569165AQ26767065-0CBBEAE7-D73C-44C8-A4DC-072A8BD3E6A3Q28368111-3F6FA0D7-FD38-4ABD-BBFA-E69FEB6D98CEQ28378361-E909BDF3-D931-4A50-983F-9D994634D576Q28654581-3CB1E10A-E8F1-4362-A159-6D5933FB8C0FQ34175952-235A36E8-7193-4235-84B4-446A419F3FE1Q34240784-2489060E-B448-4B06-9B2A-A47E5D5BE45FQ34527445-A3934303-EE92-475B-AA59-6B01E526C15DQ35314372-F09757CD-3931-4105-808F-1E8A1447B366Q36316835-0FEB2B0F-56D7-4493-8A51-4ABE6EE20A26Q36515517-04390586-E6F4-4F99-9725-3A3D7ED7E26CQ37316208-F6B99C31-DC26-4015-AB82-5A84957EEB87Q38036194-A387862C-AA9C-4A8B-83BA-4291CA18175AQ38071047-8FD0FC04-7D82-41FD-B83E-217583FF309CQ40921761-D131310C-0BD0-48F4-9086-161FB1C4DA64Q44992913-CFDB9D29-97FB-4982-8461-3BC28E4C5A10Q47696088-24A3F4A4-BA8D-4E46-8E46-A28E321910AD
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Long-term safety and efficacy profile of simvastatin.
@ast
Long-term safety and efficacy profile of simvastatin.
@en
type
label
Long-term safety and efficacy profile of simvastatin.
@ast
Long-term safety and efficacy profile of simvastatin.
@en
prefLabel
Long-term safety and efficacy profile of simvastatin.
@ast
Long-term safety and efficacy profile of simvastatin.
@en
P2093
P1476
Long-term safety and efficacy profile of simvastatin.
@en
P2093
Bocanegra TS
Boccuzzi SJ
Shapiro DR
P304
P356
10.1016/0002-9149(91)90182-K
P407
P577
1991-11-01T00:00:00Z